Research focuses on pain mechanisms at process level: NOP receptor signaling and regulation, NF‑κB activation, and growth‑factor cross‑talk. Using in vitro/in vivo models, this work maps sex differences and identifies targets to restore opioid analgesia and treat neuropathic pain.